Wattana Karnpaet PCL (BKK:NEW) Stock Based Compensation: ฿0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:NEW Wattana Karnpaet PCL BKK:NEW
75 GF Score
Price ฿104.00
GF Value ฿96.94
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Wattana Karnpaet PCL Stock Based Compensation?

Wattana Karnpaet PCL BKK:NEW 75 Stock Based Compensation is ฿0.0 Mil as of Mar. 2026. GuruFocus rates BKK:NEW with a GF Score™ of 75/100 and a GF Value™ of ฿96.94 (Fairly Valued). The stock has 1 warning sign investors should review.

Wattana Karnpaet PCL's Stock Based Compensation for the three months ended in Mar. 2026 was ฿0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0.0 Mil.

Wattana Karnpaet PCL Stock Based Compensation Related Terms

Wattana Karnpaet PCL Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Wattana Karnpaet PCL's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wattana Karnpaet PCL Stock Based Compensation Chart

Wattana Karnpaet PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wattana Karnpaet PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:NEW
75GF Score
Wattana Karnpaet PCL BKK:NEW
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wattana Karnpaet PCL Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.0 Mil.

What does a Stock Based Compensation of ฿0.0 Mil mean?
Wattana Karnpaet PCL (BKK:NEW) has a Stock Based Compensation of ฿0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Wattana Karnpaet PCL and its competitors.
Is Wattana Karnpaet PCL's Stock Based Compensation too high?
Wattana Karnpaet PCL's current Stock Based Compensation is ฿0.0 Mil. Overall, Wattana Karnpaet PCL has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's Stock Based Compensation compare to HCA and THC?
Wattana Karnpaet PCL's Stock Based Compensation of ฿0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Wattana Karnpaet PCL and its competitors. Wattana Karnpaet PCL's current Stock Based Compensation is ฿0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Fairly Valued. The stock's GF Value™ is ฿96.94, compared to a current price of ฿104.00 — trading 7.3% above its estimated fair value. The current Stock Based Compensation is ฿0.0 Mil. Wattana Karnpaet PCL's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current Stock Based Compensation is ฿0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?

Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be overvalued. The current stock price of ฿104.00 is trading 7.3% above its estimated GF Value™ of ฿96.94. GuruFocus considers Wattana Karnpaet PCL to be Fairly Valued.

Key valuation signals for BKK:NEW:

  • Stock Based Compensation: ฿0.0 Mil
  • GF Value™: ฿96.94 vs. price of ฿104.00 (7.3% above fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wattana Karnpaet PCL Business Description

Address 70/7-8 Suphakitjanya Road, Mhakkang sub-district, Muang Udonthanee district, Udonthanee, THA, 41000
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
75GF Score

Get the complete analysis for BKK:NEW

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿104.00
Price
฿96.94
GF Value